p53-Mediated repression of alpha-fetoprotein gene expression by specific DNA binding

Molecular and Cellular Biology

Volumn 19, Issue 2, 1999, Pages 1279-1288

  Lee, Kathleen C ^a   Crowe, Alison J ^a   Barton, Michelle Craig ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; PROTEIN P53;

ARTICLE; CELL CULTURE; DNA BINDING; DNA DAMAGE; GENE EXPRESSION; GENE MUTATION; HYPOXIA; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REPRESSOR GENE; STRESS; WESTERN BLOTTING;

EID: 0032929014     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.2.1279     Document Type: Article

References (89)

1. Agoff, S. N., J. Hou, D. I. H. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
2. Ang, S. L., A. Wierda, D. Wong, K. A. Stevens, S. Cascio, J. Rossant, and K. S. Zaret. 1993. The formation and maintenance of the definitive endoderm lineage in the mouse: involvement of HNF3/forkhead proteins. Development 119:1301-1315.
3. Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184.
4. Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J. N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159-171.
5. Barton, M. C., N. Madani, and B. M. Emerson. 1997. Distal enhancer regulation by promoter derepression in topologically constrained DNA in vitro. Proc. Natl. Acad. Sci. USA 94:7257-7262.
6. Camper, S. A., R. Godbout, and S. M. Tilghman. 1989. The developmental regulation of albumin and alpha-fetoprotein gene expression. Prog. Nucleic Acid Res. Mol. Biol. 36:131-143.
7. Camper, S. A., and S. M. Tilghman. 1989. Postnatal repression of the alpha-fetoprotein gene is enhancer independent. Genes Dev. 3:537-546.
8. Camper, S. A., and S. M. Tilghman. 1991. The activation and silencing of gene transcription in the liver. Bio/Technology 16:81-87.
9. Crowe, A. J., and M. J. Hayman. 1993. Post-translational modifications of the env-sea oncogene product: the role of proteolytic processing in transformation. Oncogene 8:181-189.
10. de Oca Luna, R. M., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 206-208.
11. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
12. Dobner, T., N. Horikoshi, S. Rubenwolf, and T. Shenk. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470-1473.
13. Eckner, R., T. P. Yao, E. Oldread, and D. M. Livingston. 1994. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478-2490.
14. Eizenberg, O., A. Faber-Elman, E. Gottlieb, M. Oren, V. Rotter, and M. Schwartz. 1996. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol. 16:5178-5185.
15. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Gen. 1:45-49.
16. Emerson, B. M., J. M. Nickol, and T. C. Fong. 1989. Erythroid-specific activation and derepression of the chick β-globin promoter in vitro. Cell 57: 1189-1200.
17. Enoch, T., and C. Norbury. 1995. Cellular responses to DNA damage: cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20:426-430.
18. Farmer, G., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1992. Wild-type p53 activates transcription in vitro. Nature 358:83-86.
19. Farmer, G., J. Colgan, Y. Nakatani, J. L. Manley, and C. Prives. 1996. Functional interaction between p53, the TATA-binding protein (TBP), and TBP-associated factors in vivo. Mol. Cell. Biol. 16:4295-4304.
20. Farmer, G., P. Friedlander, J. Colgan, J. L. Manley, and C. Prives. 1996. Transcriptional repression by p53 involves molecular interactions distinct from those with the TATA box binding protein. Nucleic Acids Res. 24:4281-4288.
21. Galarneau, L., J.-F. Pare, D. Allard, D. Hamel, L. Levesque, J. D. Tugwood, S. Green, and L. Belanger. 1996. The alpha-fetoprotein locus is activated by a nuclear receptor of the Drosophila Ftz-F1 family. Mol. Cell. Biol. 16:3853-3865.
22. Gallagher, M. J. and K. M. Blumenthal. 1992. Cloning and expression of wildtype and mutant forms of the cardiotonic polypeptide anthopleurin B. J. Biol. Chem. 267:13958-13963.
23. Godbout, R., R. Ingram, and S. M. Tilghman. 1986. Multiple regulatory elements in the intergenic region between the alpha-fetoprotein and albumin genes. Mol. Cell. Biol. 6:477-487.
24. Godley, L. A., J. B. Kopp, M. Eckhaus, J. J. Paglino, J. Owens, and H. E. Varmus. 1996. Wild-type p53 transgenic mice exhibit altered differentiation of the ureteric bud and possess small kidneys. Genes Dev. 10:836-850.
25. Gorski, K., M. Carneiro, and U. Schibler. 1986. Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767-776.
26. Graeber, T. G., C. Osmanian, T. Jacks, D. E. Housman, D. J. Koch, S. W. Lowe, and A. J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379:88-91.
27. Graeber, T. G., J. F. Peterson, M. Tsai, K. Monica, A. J. Fornace, Jr., and A. J. Giaccia. 1994. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264-6277.
28. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-464.
29. Gray, S., and M. Levine. 1996. Transcriptional repression in development. Curr. Opin. Cell Biol. 8:358-364.
30. Gu, W., and R. G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595-606.
31. Gu, W., X.-L. Shi, and R. G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819-823.
32. Haffner, R., and M. Oren. 1995. Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5:84-90.
33. Hainault, P., and J. Milner. 1993. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53:4469-4473.
34. Hanna-Rose, W., and U. Hansen. 1996. Active repression mechanisms of eukaryotic transcription repressors. Trends Genet. 12:229-234.
35. Hawley, R. S., and S. H. Friend. 1996. Strange bedfellows in even stranger places: the role of ATM in meiotic cells, lymphocytes, tumors, and its functional links to 53. Genes Dev. 10:2383-2388.
36. Hinds, P., C. Finlay, and A. J. Levine. 1989. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol. 63:739-746.
37. Horikoshi, N., K. Maguire, A. Kralli, E. Maldonado, U. Reinberg, and R. Weinmann. 1991. Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. Proc. Natl. Acad. Sci. USA 88:5124-5128.
38. Hundley, J. E., S. K. Koester, D. A. Troyer, S. G. Hisenbeck, M. A. Subler, and J. J. Windle. 1997. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol. Cell. Biol. 17:723-731.
39. Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. 1992. Regulation of the specific DNA binding function of p53. Cell 71:875-886.
40. Hupp, T. R., and D. P. Lane. 1994. Allosteric activation of latent p53 tetramers. Curr. Biol 4:865-875.
41. Ikeda, K., J.-P. Halle, G. Stelzer, M. Meisterernst, and K. Kawakami. 1998. Involvement of negative cofactor NC2 in active repression by zinc finder-homeodomain transcription factor AREB6. Mol. Cell. Biol. 18:10-18.
42. Jackson, D. A., K. E. Rowader, K. Stevens, C. Jiang, P. Milos, and K. S. Zaret. 1993. Modulation of liver-specific transcription by interactions between hepatocyte nuclear factor 3 and nuclear factor 1 binding DNA in close apposition. Mol. Cell. Biol. 13:2401-2410.
43. Jayaraman, L., G. K. M. Kanneganti, C. Zhu, T. Curran, S. Xanthoudakis, and C. Prives. 1997. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev. 11:558-570.
44. Johnson, P. 1993. Identification of C/EBP basic region residues involved in DNA sequence recognition and half-site spacing preference. Mol. Cell. Biol. 13:6919-6930.
45. Johnson, P. F. 1990. Transcriptional activators in hepatocytes. Cell Growth Diff. 1:47-52.
46. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10: 1054-1072.
47. Kumar, G. K., A. A. Saadi, S.-S. Yang, and R. S. McCaughey. 1979. Ataxiatelangiectasia and hepatocellular carcinoma. Am. J. Med. Sci. 278:157-160.
48. Lai, E., V. R. Prezioso, E. Smith, O. Litvin, R. H. Costa, and J. E. Darnell. 1990. HNF-3A, a hepatocyte-enriched transcription factor of novel structure is regulated transcriptionally. Genes Dev. 4:1427-1436.
49. Leng, X., A. J. Cooney, S. Y. Tsae, and M.-J. Tsai. 1996. Molecular mechanisms of COUP-TF-mediated transcriptional repression: evidence for transrepression and active repression. Mol. Cell. Biol. 16:2332-2340.
50. Leveillard, T., L. Andera, N. Bissonnette, L. Schaeffer, L. Bracco, J.-M. Egly, and B. Wasylyk. 1996. Functional interactions between p53 and TFIIH complex are affected by tumour-associated mutations. EMBO J. 15:1615-1624.
51. Levine, A. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
52. Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387: 823-827.
53. Liu, X., and A. J. Berk. 1995. Reversal of in vitro p53 squelching by both TFIIB and TFIID. Mol. Cell. Biol. 15:6474-6478.
54. Ludwig, R. L., S. Bates, and K. H. Vousden. 1996. Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function. Mol. Cell. Biol. 16:4952-4960.
55. Lutzker, S., and A. J. Levine. 1996. A functionally inactive p53 protein in teratocarcinoma cells is activated by either DNA damage or cellular differentiation. Nat. Med. 2:804-810.
56. Maheswaran, S., C. Englert, P. Bennet, G. Heinrich, and D. A. Haber. 1995. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis. Genes Dev. 9:2143-2156.
57. Maire, P., J. Wuarin, and U. Schibler. 1989. The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science 244:343-346.
58. Martinez, J., I. Georgoff, J. Marinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
59. McLure, K. G., and P. W. K. Lee. 1998. How p53 binds DNA as a tetramer. EMBO J. 17:3342-3350.
60. Milne, D. M., R. H. Palmer, D. G. Campbell, and D. W. Meek. 1992. Phosphorylation of the p53 tumor suppressor protein at three N-terminal sites by a novel casein kinase I-like enzyme. Oncogene 7:1361-1369.
61. Murphy, M., A. Hinman, and A. J. Levine. 1996. Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10: 2971-2980.
62. Nelson, R., and G. Long. 1989. A general method of site-specific mutagenesis using a modification of the Thermus aquaticus polymerase chain reaction. Anal. Biochem. 180:147-151.
63. Opdecamp, K., C. Szpirer, and J. Szpirer. 1991. Major chromatin changes accompany extinction of alpha-fetoprotein gene in hepatoma x fibroblast hybrids. Somatic Cell Mol. Genet. 17:49-55.
64. Ori, A., A. Zauberman, G. Doitsch, N. Paran, M. Oren, and Y. Shaul. 1998. p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53. EMBO J. 17:544-553.
65. Qi, J.-S., V. Desai-Yajnik, Y. Yuan, and H. H. Samuels. 1997. Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression. Mol. Cell. Biol. 17:7195-7297.
66. Rotter, V., R. Aloni-Grinstein, D. Schwartz, N. B. Elkind, A. Simons, R. Wolkowicz, M. Lavigne, P. Beserman, A. Kapon, and N. Goldfiner. 1994. Does wild-type p53 play a role in normal cell differentiation? Sem. Cancer Biol. 5:229-236.
67. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
68. Shen, Y., and T. Shenk. 1994. Relief of p53-mediated transcription repression by the adenovirus E1B 19-kDa protein or the cellular bcl-2 protein. Proc. Natl. Acad. Sci. USA 91:8940-8944.
69. Soddu, S., G. Blandino, R. Scardigli, R. Martinelli, M. G. Rizzo, M. Crescenzi, and A. Sacchi. 1996. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol. 16:487-495.
70. Soddu, S., G. Blandino, R. Scardigli, S. Soen, A. Marchetti, M. G. Rizzo, G. Bossi, L. Cimino, M. Crescenzi, and A. Sacchi. 1996. Interference with p53 protein inhibits hematopoietic and muscle differentiation. J. Cell Biol. 134: 193-204.
71. Spear, B. T. 1994. Mouse a-fetoprotein gene 5′ regulatory elements are required for postnatal regulation by raf and Rif. Mol. Cell. Biol. 14:6497-6505.
72. Spear, B. T., T. Longley, S. Moulder, S. L. Wang, and M. L. Peterson. 1995. A sensitive lacZ-based expression vector for analyzing transcriptional control elements in eukaryotic cells. DNA Cell Biol. 14:635-642.
73. Tabor, E. 1994. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J. Med. Virol. 42:357-365.
74. Tan, T.-H., J. Wallis, and A. J. Levine. 1986. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex. J. Virol. 59:574-583.
75. Tilghman, S. M. 1985. The structure and regulation of the alpha-fetoprotein and albumin genes. Oxf. Surv. Eukaryotic Genes 2:160-206.
76. Vacher, J., and S. M. Tilghman. 1990. Dominant negative regulation of the mouse alpha-fetoprotein gene in adult liver. Science 250:1732-1735.
77. Waldman, T. A., and K. R. McIntire. 1972. Serum alpha fetoprotein levels in patients with ataxia telangiectasia. Lancet 2:1112-1115.
78. Wang, Q., G. P. Zambetti, and D. P. Suttle. 1997. Inhibition of DNA topoisomerase IIα gene expression by the p53 tumor suppressor. Mol. Cell. Biol. 17:389-397.
79. Wang, X. W., K. Forrester, J. Yeh, M. A. Feitelson, J.-R. Gu, and C. C. Harris. 1994. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl. Acad. Sci. USA 91:2230-2234.
80. Weinberg, W. C., C. G. Azzoli, K. Chapman, A. J. Levine, and S. H. Yuspa. 1995. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene 10:2271-2279.
81. Wen, P., E. R. Groupp, G. Buzard, N. Crawford, and J. Locker. 1991. Enhancer, repressor, and promoter specificities combine to regulate the rat α-fetoprotein Gene. DNA Cell Biol. 10:525-536.
82. Wen, P., and J. Locker. 1994. A novel hepatocytic transcription factor that binds the α-fetoprotein promoter-linked coupling element. Mol. Cell. Biol. 14:6616-6626.
83. Wu, H., M. Wade, L. Krall, J. Grisham, Y. Xiong, and T. Van Dyke. 1996. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10:245-260.
84. Xu, Y., T. Ashley, E. E. Brainerd, R. T. Bronson, M. S. Meyn, and D. Baltimore. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:2411-2422.
85. Yap, N., C.-L. Yu, and S.-Y. Cheng. 1996. Modulation of the transcriptional activity of thyroid hormone receptors by the tumor suppressor p53. Proc. Natl. Acad. Sci. USA 93:4273-4277.
86. Yew, P. R., X. Liu, and A. J. Berk. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8:190-202.
87. Zambetti, G. P., J. Bargonetti, K. Walker, C. Prives, and A. J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6:1143-1152.
88. Zaret, K. S., and K. Stevens. 1995. Expression of a highly unstable and insoluble transcription factor in Escherichia coli: purification and characterization of the fork head homolog HNF3alpha. Protein Expr. Purif. 6:821-825.
89. Zhang, D.-E., P. R. Hoyt, and J. Papaconstantinou. 1990. Localization of DNA protein-binding sites in the proximal and distal promoter regions of the mouse α-fetoprotein gene. J. Biol. Chem. 265:3382-3391.